Daniil Georgiyevich Nemenov
Amministratore Delegato presso Aviks Ltd.
Profilo
Daniil Georgiyevich Nemenov is currently working as a Medical Director at TheraMAB LLC since 2011, as a Medical Director at Promogen-MAT LLC since 2011, and as the Director General at Aviks Ltd.
since 2014.
Previously, he worked as a Senior VP-Clinical Development & Operations at Ovoca Bio Plc.
He also worked as a Research Associate at the Russian Academy of Sciences from 2008 to 2009, at the Russian State Medical University from 2006 to 2008, and as a Project Manager at Novartis Pharma LLC from 2009 to 2011.
Dr. Nemenov holds a doctorate degree from I.M.
Sechenov First Moscow State Medical University.
Posizioni attive di Daniil Georgiyevich Nemenov
| Società | Posizione | Inizio |
|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Aviks Ltd.
 Aviks Ltd. Miscellaneous Commercial ServicesCommercial Services Aviks Ltd. engages in the development of treatment for female sexual and reproductive dysfunctions. Its products is called Libicore. The company was founded on July 3, 2012 and is headquartered in Moscow, Russia. | Amministratore Delegato | 25/02/2019 |
Promogen-MAT LLC
 Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Precedenti posizioni note di Daniil Georgiyevich Nemenov
| Società | Posizione | Fine |
|---|---|---|
| Novartis Pharma LLC | Corporate Officer/Principal | 01/01/2011 |
| Russian Academy of Sciences | Corporate Officer/Principal | 01/01/2009 |
| Russian State Medical University | Corporate Officer/Principal | 01/01/2008 |
| OVOCA BIO PLC | Direttore operativo | - |
Formazione di Daniil Georgiyevich Nemenov
| I.M. Sechenov First Moscow State Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OVOCA BIO PLC | Health Technology |
| Aziende private | 4 |
|---|---|
| Novartis Pharma LLC | |
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
Promogen-MAT LLC
Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Health Services |
Aviks Ltd.
Aviks Ltd. Miscellaneous Commercial ServicesCommercial Services Aviks Ltd. engages in the development of treatment for female sexual and reproductive dysfunctions. Its products is called Libicore. The company was founded on July 3, 2012 and is headquartered in Moscow, Russia. | Commercial Services |
- Borsa valori
- Insiders
- Daniil Georgiyevich Nemenov